Detalhe da pesquisa
1.
Tackling COVID-19 with neutralizing monoclonal antibodies.
Cell
; 184(12): 3086-3108, 2021 06 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34087172
2.
Tackling COVID-19 with neutralizing monoclonal antibodies.
Cell
; 184(17): 4593-4595, 2021 Aug 19.
Artigo
Inglês
| MEDLINE | ID: mdl-34416148
3.
A pan-influenza antibody inhibiting neuraminidase via receptor mimicry.
Nature
; 618(7965): 590-597, 2023 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-37258672
4.
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift.
Nature
; 602(7898): 664-670, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-35016195
5.
Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies.
Nature
; 598(7880): 342-347, 2021 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34464958
6.
Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19.
N Engl J Med
; 385(13): 1184-1195, 2021 09 23.
Artigo
Inglês
| MEDLINE | ID: mdl-34347950
7.
Author Correction: A pan-influenza antibody inhibiting neuraminidase via receptor mimicry.
Nature
; 619(7970): E50, 2023 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-37407829
8.
Potent broadly neutralizing antibody VIR-3434 controls hepatitis B and D virus infection and reduces HBsAg in humanized mice.
J Hepatol
; 79(5): 1129-1138, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37459920
9.
Efficacy and Safety of Sarilumab in Hospitalized Patients With Coronavirus Disease 2019: A Randomized Clinical Trial.
Clin Infect Dis
; 75(1): e380-e388, 2022 08 24.
Artigo
Inglês
| MEDLINE | ID: mdl-35219277
10.
Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial.
JAMA
; 327(5): 432-441, 2022 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35029629
11.
Dupilumab does not affect correlates of vaccine-induced immunity: A randomized, placebo-controlled trial in adults with moderate-to-severe atopic dermatitis.
J Am Acad Dermatol
; 80(1): 158-167.e1, 2019 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-30092324
12.
How a Potent Anti-neuraminidase Monoclonal Antibody Navigates Recent Immune-evasive Influenza Strains: A Structural Study by Single-particle CryoEM.
Microsc Microanal
; 29(29 Suppl 1): 927, 2023 Jul 22.
Artigo
Inglês
| MEDLINE | ID: mdl-37613467
13.
Pandemic preparedness strategies must go beyond vaccines.
Sci Transl Med
; 15(690): eadd3055, 2023 04 05.
Artigo
Inglês
| MEDLINE | ID: mdl-37018420
14.
Accelerating antiviral drug discovery: lessons from COVID-19.
Nat Rev Drug Discov
; 22(7): 585-603, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37173515
15.
Identification of a mutant PfCRT-mediated chloroquine tolerance phenotype in Plasmodium falciparum.
PLoS Pathog
; 6(5): e1000887, 2010 May 13.
Artigo
Inglês
| MEDLINE | ID: mdl-20485514
16.
An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies.
Nat Med
; 28(3): 490-495, 2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-35046573
17.
Preclinical and clinical experience with dupilumab on the correlates of live attenuated vaccines.
J Allergy Clin Immunol Glob
; 1(1): 9-15, 2022 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-37780074
18.
Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains.
Nat Commun
; 13(1): 3824, 2022 07 02.
Artigo
Inglês
| MEDLINE | ID: mdl-35780162
19.
ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies.
Science
; 377(6607): 735-742, 2022 08 12.
Artigo
Inglês
| MEDLINE | ID: mdl-35857703
20.
Imprinted antibody responses against SARS-CoV-2 Omicron sublineages.
Science
; 378(6620): 619-627, 2022 11 11.
Artigo
Inglês
| MEDLINE | ID: mdl-36264829